Lunai Bioworks(LNAI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LNAI Lunai Bioworks

美国阵亡战士纪念日休市 05-22 16:00:00 EDT

2.26

-0.06

-2.62%

盘后2.19

-0.07-3.10%

19:47 EDT

最高2.40	最低2.11	成交量20.60万
今开2.26	昨收2.32	日振幅12.50%
总市值1,025万	流通市值857.56万	总股本453.39万
成交额46.08万	换手率5.43%	流通股本379.45万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LNAI","market":"US","secType":"STK","nameCN":"Lunai Bioworks","latestPrice":2.26,"timestamp":1779480000000,"preClose":2.3208,"halted":0,"volume":205974,"hourTrading":{"tag":"盘后","latestPrice":2.19,"preClose":2.26,"latestTime":"19:47 EDT","volume":9034,"amount":19379.1703,"timestamp":1779493677953,"change":-0.07,"changeRate":-0.030973,"amplitude":0.066372},"delay":0,"changeRate":-0.026197862805929163,"floatShares":3794525,"shares":4533900,"eps":-58.0025,"marketStatus":"美国阵亡战士纪念日休市","change":-0.0608,"latestTime":"05-22 16:00:00 EDT","open":2.26,"high":2.4,"low":2.11,"amount":460817.26765560004,"amplitude":0.124957,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-58.0025,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1779782400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":2.3208,"preHourTrading":{"tag":"盘前","latestPrice":2.38,"preClose":2.3208,"latestTime":"09:28 EDT","volume":8192,"amount":19456.0876544,"timestamp":1779456517754,"change":0.0592,"changeRate":0.025508,"amplitude":0.193899},"postHourTrading":{"tag":"盘后","latestPrice":2.19,"preClose":2.26,"latestTime":"19:47 EDT","volume":9034,"amount":19379.1703,"timestamp":1779493677953,"change":-0.07,"changeRate":-0.030973,"amplitude":0.066372},"volumeRatio":1.4496186871661185,"impliedVol":1.4337,"impliedVolPercentile":0.85},"requestUrl":"/m/hq/s/LNAI","defaultTab":"news","newsList":[{"id":"1145485751","title":"联邦法官批准Lunai Bioworks加速取证程序，以识别“裸卖空”交易者","url":"https://stock-news.laohu8.com/highlight/detail?id=1145485751","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145485751?lang=zh_cn&edition=full","pubTime":"2026-05-22 21:17","pubTimestamp":1779455837,"startTime":"0","endTime":"0","summary":"联邦法院近日作出裁决，批准了Lunai Bioworks公司提出的加速取证请求。这一决定将使该公司能够迅速获取相关交易记录，旨在查明并确认涉嫌对其股票进行“裸卖空”操作的交易者身份。\n所谓“裸卖空”，是指卖方在未实际借入股票的情况下直接进行卖空交易，这种行为在多数市场受到严格监管甚至禁止。Lunai Bioworks此次获得法院支持的取证程序，标志着其在应对潜在市场操纵行为方面取得了关键进展。通过加速发现程序，公司有望更快地收集证据，厘清交易活动中的异常模式。\n这一法律行动反映出上市公司日益关注并积极应对可能影响股价的市场交易行为。随着取证程序的推进，后续进展或将引起市场参与者的密切关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LNAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637272438","title":"Lunai Bioworks宣布1比8反向拆股，5月22日生效以维持纳斯达克上市地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2637272438","media":"环球市场播报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637272438?lang=zh_cn&edition=full","pubTime":"2026-05-21 03:05","pubTimestamp":1779303900,"startTime":"0","endTime":"0","summary":"AI驱动的生命科学公司Lunai Bioworks周三宣布，将对其普通股实施1比8的反向股票分割。该拆股将于美国东部时间2026年5月22日凌晨12：01正式生效，当日纳斯达克开盘后将以拆股调整后的价格进行交易，股票代码仍为“LNAI”，但将启用新的CUSIP编号。　　为改善基本面并创造新收入来源，Lunai Bioworks近期实施了一系列战略举措。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-21/doc-inhyquqa6091712.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["FTEC","NVIW.SI","QDEC","NJAN","09086","NOCT","BK1147","TECS","03455","GPIQ","QQQE","BK4139","07568","TQQQ","SQQQ","QQQM","IYW","QQQ","QQQJ","09834","07522","NAPR","PSQ","QYLG","QDTE","QLD","BK4007","03034","07266","02834","MNQmain","JEPQ","TQQY","QQQX","LNAI","QQQY","07261","QQQA","NJUL","QMAR","QID","ONEQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111041885","title":"Lunai Bioworks完成2000万美元优先股发行，收购中枢神经递送与神经治疗知识产权","url":"https://stock-news.laohu8.com/highlight/detail?id=1111041885","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111041885?lang=zh_cn&edition=full","pubTime":"2026-05-04 21:35","pubTimestamp":1777901711,"startTime":"0","endTime":"0","summary":"Lunai Bioworks已成功完成一笔价值2000万美元的优先股发行。此次融资的核心目的在于收购中枢神经递送及神经治疗领域的相关知识产权组合。这一战略性举措标志着该公司在强化其神经科学平台方面迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196380438","title":"Lunai Bioworks 以每股1.50美元固定转换价完成2000万美元战略交易，收购适用于阿尔茨海默症CNS疗法且具有广泛CNS递送应用的Bbb递送平台","url":"https://stock-news.laohu8.com/highlight/detail?id=1196380438","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196380438?lang=zh_cn&edition=full","pubTime":"2026-03-26 20:52","pubTimestamp":1774529532,"startTime":"0","endTime":"0","summary":"Lunai Bioworks公司已成功执行一项价值2000万美元的战略交易。该交易采用每股1.50美元的固定转换价格，核心内容是收购Bbb递送平台。此平台专门用于中枢神经系统阿尔茨海默症疗法的递送，并具备广泛的中枢神经系统递送应用潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618696959","title":"Lunai Bioworks Inc.盘中异动 急速下跌5.05%报0.209美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618696959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618696959?lang=zh_cn&edition=full","pubTime":"2026-03-11 01:28","pubTimestamp":1773163718,"startTime":"0","endTime":"0","summary":"北京时间2026年03月11日01时28分，Lunai Bioworks Inc.股票出现异动，股价快速下挫5.05%。截至发稿，该股报0.209美元/股，成交量29.0909万股，换手率1.20%，振幅9.09%。Lunai Bioworks Inc.股票所在的生物技术行业中，整体涨幅为1.97%。其相关个股中，Longeveron Inc.、Cingulate Inc C/Wts 10/12/2026 、Acurx Pharmaceuticals, Inc.涨幅较大，Longeveron Inc.、Acurx Pharmaceuticals, Inc.、Biorestorative Therapies, Inc.较为活跃，换手率分别为1066.36%、983.18%、694.08%，振幅较大的相关个股有Longeveron Inc.、Cingulate Inc C/Wts 10/12/2026 、Acurx Pharmaceuticals, Inc.，振幅分别为109.01%、60.16%、46.54%。Lunai Bioworks Inc.公司简介：Lunai Bioworks Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031101283895474c92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031101283895474c92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LNAI","RENB","BK4139"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1175041179","title":"Lunai Bioworks公司CEO与CFO自愿同意在休假期间暂缓领取薪酬——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1175041179","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175041179?lang=zh_cn&edition=full","pubTime":"2026-03-06 05:50","pubTimestamp":1772747457,"startTime":"0","endTime":"0","summary":"根据最新提交至美国证券交易委员会（SEC）的文件显示，Lunai Bioworks公司首席执行官与首席财务官已主动达成一致，将在公司实施强制休假措施期间，自愿暂缓领取其个人薪酬。\n这一决定体现了管理层在当前特殊时期与公司共渡难关的坚定承诺。通过暂时推迟薪资支付，公司有望在业务调整期间优化现金流管理，为后续运营恢复保留更多财务灵活性。\n","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191374910","title":"Lunai Bioworks公司于2026年2月27日在美国和加拿大实施员工临时休假措施 - 美国证券交易委员会文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1191374910","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191374910?lang=zh_cn&edition=full","pubTime":"2026-03-06 05:48","pubTimestamp":1772747306,"startTime":"0","endTime":"0","summary":"根据一份提交给美国证券交易委员会的文件，Lunai Bioworks公司已决定自2026年2月27日起，对其在美国和加拿大业务的员工实施临时休假措施。此举标志着公司运营策略的调整。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LNAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614970548","title":"Lunai Bioworks Inc.盘中异动 快速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614970548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614970548?lang=zh_cn&edition=full","pubTime":"2026-02-28 04:56","pubTimestamp":1772225778,"startTime":"0","endTime":"0","summary":"北京时间2026年02月28日04时56分，Lunai Bioworks Inc.股票出现波动，股价急速跳水5.00%。截至发稿，该股报0.380美元/股，成交量25.7378万股，换手率1.06%，振幅4.85%。Lunai Bioworks Inc.股票所在的生物技术行业中，整体涨幅为0.80%。其相关个股中，Ensysce Biosciences, Inc.、Edesa Biotech, Inc.、Cardio Diagnostics Holdings Inc.涨幅较大，Ensysce Biosciences, Inc.、Cardio Diagnostics Holdings Inc.、Edesa Biotech, Inc.较为活跃，换手率分别为7585.73%、1007.93%、488.05%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Edesa Biotech, Inc.、Ensysce Biosciences, Inc.，振幅分别为82.34%、69.03%、51.85%。Lunai Bioworks Inc.公司简介：Lunai Bioworks Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022804561995424e92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022804561995424e92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LNAI","RENB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612999704","title":"Lunai Bioworks Inc.盘中异动 股价大跌8.78%报0.670美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612999704","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612999704?lang=zh_cn&edition=full","pubTime":"2026-02-17 22:43","pubTimestamp":1771339409,"startTime":"0","endTime":"0","summary":"北京时间2026年02月17日22时43分，Lunai Bioworks Inc.股票出现异动，股价急速跳水8.78%。截至发稿，该股报0.670美元/股，成交量10.9569万股，换手率0.47%，振幅3.95%。Lunai Bioworks Inc.股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Polaryx Therapeutics, Inc.、Liminatus Pharma Inc C/Wts 30/04/2030 、Biovie Inc C/Wts 08/08/2030涨幅较大，Ernexa Therapeutics Inc.、Quince Therapeutics, Inc.、Moolec Science Sa较为活跃，换手率分别为67.17%、36.32%、33.27%，振幅较大的相关个股有Polaryx Therapeutics, Inc.、Xtl生物制药、Eyepoint, Inc.，振幅分别为23.24%、18.82%、18.62%。Lunai Bioworks Inc.公司简介：Lunai Bioworks Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021722432997a6671d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021722432997a6671d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RENB","LNAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171837745","title":"Lunai Bioworks (纳斯达克: LNAI) 携手临床阶段合作伙伴启动AI肿瘤学试点项目，分析转移性结直肠癌生存期随机II期试验数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1171837745","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171837745?lang=zh_cn&edition=full","pubTime":"2026-02-09 22:18","pubTimestamp":1770646723,"startTime":"0","endTime":"0","summary":"Lunai Bioworks (纳斯达克: LNAI) 近日宣布，与一家临床阶段的合作伙伴共同启动了一项人工智能肿瘤学试点项目。该项目的核心任务是利用先进的人工智能技术，对一项针对转移性结直肠癌患者的随机II期生存期临床试验数据进行深度分析。此举旨在探索AI在加速肿瘤学研究与药物开发方面的巨大潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LNAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606730216","title":"Lunai Bioworks Inc.盘中异动 快速拉升5.08%报0.900美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606730216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606730216?lang=zh_cn&edition=full","pubTime":"2026-01-27 23:50","pubTimestamp":1769529013,"startTime":"0","endTime":"0","summary":"北京时间2026年01月27日23时50分，Lunai Bioworks Inc.股票出现波动，股价快速上涨5.08%。截至发稿，该股报0.900美元/股，成交量21.2002万股，换手率0.90%，振幅9.33%。Lunai Bioworks Inc.股票所在的生物技术行业中，整体涨幅为1.53%。其相关个股中，Biomx Inc.、Briacell Therapeutics Corp C/Wts 、Lisata Therapeutics, Inc.涨幅较大，Biomx Inc.、Vyome Holdings, Inc.、Genenta Science Spa较为活跃，换手率分别为1543.34%、736.96%、227.46%，振幅较大的相关个股有Biomx Inc.、Vyome Holdings, Inc.、Novabay Pharmaceuticals, Inc.，振幅分别为53.90%、39.87%、36.19%。Lunai Bioworks Inc.公司简介：Lunai Bioworks Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127235013a6b3b484&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127235013a6b3b484&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LNAI","RENB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594233094","title":"Lunai Bioworks Inc.盘中异动 股价大涨6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594233094","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594233094?lang=zh_cn&edition=full","pubTime":"2025-12-24 22:54","pubTimestamp":1766588048,"startTime":"0","endTime":"0","summary":"北京时间2025年12月24日22时54分，Lunai Bioworks Inc.股票出现异动，股价急速拉升6.02%。截至发稿，该股报1.052美元/股，成交量2887股，换手率0.01%，振幅1.08%。Lunai Bioworks Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Indaptus Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts 、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Dermata Therapeutics, Inc.、Indaptus Therapeutics, Inc.、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为1691.95%、1009.79%、35.50%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、Citius Pharmaceuticals, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为51.00%、35.58%、20.00%。Lunai Bioworks Inc.公司简介：Lunai Bioworks Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224225409953b9d5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224225409953b9d5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RENB","LNAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1158338920","title":"Lunai Bioworks获得首份许可意向书，标志着在类人癌症模型中实现完全肿瘤退化的重大突破","url":"https://stock-news.laohu8.com/highlight/detail?id=1158338920","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158338920?lang=zh_cn&edition=full","pubTime":"2025-11-25 20:46","pubTimestamp":1764074773,"startTime":"0","endTime":"0","summary":"Lunai Bioworks获得首份许可意向书，标志着在类人癌症模型中实现完全肿瘤退化的重大突破","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LNAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586440790","title":"Lunai Bioworks Inc.盘中异动 早盘快速拉升5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586440790","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586440790?lang=zh_cn&edition=full","pubTime":"2025-11-24 23:21","pubTimestamp":1763997661,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日23时21分，Lunai Bioworks Inc.股票出现波动，股价快速拉升5.24%。截至发稿，该股报1.31美元/股，成交量2.6719万股，换手率0.11%，振幅6.66%。Lunai Bioworks Inc.股票所在的生物技术行业中，整体涨幅为0.83%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Enlivex Therapeutics Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Enlivex Therapeutics Ltd.、Pasithea Therapeutics Corp.、Osr Holdings, Inc.较为活跃，换手率分别为633.82%、457.55%、69.59%，振幅较大的相关个股有Enlivex Therapeutics Ltd.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Pasithea Therapeutics Corp.，振幅分别为47.95%、42.12%、39.27%。Lunai Bioworks Inc.公司简介：Lunai Bioworks Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511242321029517b73e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511242321029517b73e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RENB","LNAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.renovarogroup.com","stockEarnings":[{"period":"1week","weight":0.0984},{"period":"1month","weight":-0.1305},{"period":"3month","weight":-0.482},{"period":"6month","weight":-0.7722},{"period":"1year","weight":-0.9153},{"period":"ytd","weight":-0.6796}],"compareEarnings":[{"period":"1week","weight":0.0088},{"period":"1month","weight":0.0484},{"period":"3month","weight":0.0815},{"period":"6month","weight":0.1314},{"period":"1year","weight":0.2788},{"period":"ytd","weight":0.0934}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lunai Bioworks Inc.于2011年1月18日在特拉华州注册成立，通过三家子公司运营：Renovaro Biosciences、Renovaro Cube和BioSymetrics。Renovaro Cube，包括GediCube Intl。Ltd.及其子公司，于2024年2月13日被收购，而BioSymetrics及其子公司于2025年4月8日被收购。Renovaro Biosciences是该公司的生物技术部门，研究重点是开发旨在加强免疫反应的同种异体细胞和基因疗法，旨在支持长期癌症缓解。继收购GediCube INTL.后，Lunai越来越强调分子诊断和肿瘤技术。该公司的发展领域包括针对胰腺癌、肝癌、三阴性乳腺癌、头颈癌等实体瘤的创新治疗性疫苗接种平台。它的方法利用工程化供体细胞和分子诊断技术，有可能提供“现成的”治疗方案，减少诊断和治疗之间的延迟。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":0.014032},{"month":2,"riseRate":0.375,"avgChangeRate":-0.059392},{"month":3,"riseRate":0.375,"avgChangeRate":-0.055345},{"month":4,"riseRate":0.25,"avgChangeRate":-0.096615},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.055282},{"month":6,"riseRate":0.375,"avgChangeRate":-0.147122},{"month":7,"riseRate":0.625,"avgChangeRate":-0.018947},{"month":8,"riseRate":0.625,"avgChangeRate":0.533577},{"month":9,"riseRate":0.375,"avgChangeRate":-0.022213},{"month":10,"riseRate":0.5,"avgChangeRate":-0.035033},{"month":11,"riseRate":0.75,"avgChangeRate":0.142505},{"month":12,"riseRate":0.375,"avgChangeRate":-0.12056}],"exchange":"NASDAQ","name":"Lunai Bioworks","nameEN":"Lunai Bioworks"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lunai Bioworks(LNAI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lunai Bioworks(LNAI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lunai Bioworks,LNAI,Lunai Bioworks股票,Lunai Bioworks股票老虎,Lunai Bioworks股票老虎国际,Lunai Bioworks行情,Lunai Bioworks股票行情,Lunai Bioworks股价,Lunai Bioworks股市,Lunai Bioworks股票价格,Lunai Bioworks股票交易,Lunai Bioworks股票购买,Lunai Bioworks股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lunai Bioworks(LNAI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lunai Bioworks(LNAI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}